Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2014
NUT midline carcinoma: an aggressive intrathoracic neoplasm
Sameer A Parikh, Christopher A French, Brian A Costello, et al.
The Journal of Urology
|
May 18, 2012
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis
Simon P Kim, R Houston Thompson, Stephen A Boorjian, et al.
BJU International
|
August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes
Sarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.
European Urology
|
May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis
Bimal Bhindi, Igor Frank, Ross J Mason, et al.
Urology
|
August 22, 2016
Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study
Daniel D Joyce, Sarah P Psutka, Ryan T Groeschl, et al.
European Urology
|
July 19, 2018
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
Bimal Bhindi, R Houston Thompson, Christine M Lohse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
Assessing the Current Stage of Burnout in Hematology-Oncology Faculty and Trainees- Is There a Path to Remission?
Savannah S Liddell, Amye J Tevaarwerk, Brittany L Siontis, et al.
The Journal of Urology
|
August 21, 2015
Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer
Sarah P Psutka, Stephen A Boorjian, Michael R Moynagh, et al.
Investigational New Drugs
|
September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies
Joleen M Hubbard, Jun Yin, Erin L Schenk, et al.
International Journal of Molecular Sciences
|
November 4, 2017
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma
Karthik V Giridhar, Carlos P Sosa, David W Hillman, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2014
NUT midline carcinoma: an aggressive intrathoracic neoplasm
Sameer A Parikh, Christopher A French, Brian A Costello, et al.
The Journal of Urology
|
May 18, 2012
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis
Simon P Kim, R Houston Thompson, Stephen A Boorjian, et al.
BJU International
|
August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes
Sarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.
European Urology
|
May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis
Bimal Bhindi, Igor Frank, Ross J Mason, et al.
Urology
|
August 22, 2016
Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study
Daniel D Joyce, Sarah P Psutka, Ryan T Groeschl, et al.
European Urology
|
July 19, 2018
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
Bimal Bhindi, R Houston Thompson, Christine M Lohse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
Assessing the Current Stage of Burnout in Hematology-Oncology Faculty and Trainees- Is There a Path to Remission?
Savannah S Liddell, Amye J Tevaarwerk, Brittany L Siontis, et al.
The Journal of Urology
|
August 21, 2015
Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer
Sarah P Psutka, Stephen A Boorjian, Michael R Moynagh, et al.
Investigational New Drugs
|
September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies
Joleen M Hubbard, Jun Yin, Erin L Schenk, et al.
International Journal of Molecular Sciences
|
November 4, 2017
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma
Karthik V Giridhar, Carlos P Sosa, David W Hillman, et al.
Page
of 12